Liver function effects of SGLT2 inhibitor and GLP‐1 receptor agonist combination treatment in patients with type 2 diabetes (post hoc analysis of RECAP study)

ABSTRACT Aim The favor effect on liver disease by odium‐glucose cotransporter inhibitor (SGLT2i) and GLP‐1 receptor agonist (GLP1Ra) was reported; however, the effect of the combination treatment of these drugs was not well known. Methods We retrospectively analyzed data for 643 patients with type 2...

Descrición completa

Detalles Bibliográficos

Principais autores:	Daisuke Tsuriya, Kazuo Kobayashi, Kei Takeshita, Takuya Hashimoto, Moritsugu Kimura, Yoshimi Muta, Hisashi Yokomizo, Yuichi Takashi, Shunichiro Tsukamoto, Kouichi Tamura, Keizo Kanasaki, Daiji Kawanami, Masao Toyoda
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2025-07-01
Series:	Journal of Diabetes Investigation
Assuntos:	FIB‐4 index GLP‐1 receptor agonist Sodium‐glucose cotransporter inhibitor
Acceso en liña:	https://doi.org/10.1111/jdi.70066
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!